Skip to main content

Innate versus adaptive: new targets in immunological therapy

Cancer cell and lymphocyte
Barts & the London, Charterhouse Square, London, EC1M 6BQ. UK

The BSI's London Immunology Group has organised a one-day meeting around the theme of immunotherapy and discussion on targeting the innate and adaptive immune systems. Registration is now closed

The day will be split into 3 sessions:

10.00-10.25 Registration with coffee
Session 1: Immune evolution Chair Suchita Nadkarni
10.25-10.30  Welcome address. Suchita Nadkarni, LIG secretary
10.30-11.00 Professor Jim Kaufman (Cambridge)
11.00-11.30 Dr Serge Mostowy (Imperial)
Submitted Abstracts
11.30-11.45 Shanthini Crusz et al (QMUL)
11.45-12.00 Damilola Pinheiro et al (Imperial)
12.00-13.00 LUNCH
 
Session 2: Innate immunity: targets for disease Chair: Kevin Woollard
13.00-13.30 Dr Andrew Stagg (QMUL)
Submitted Abstracts
13.30-13.45 George Robinson et al (UCL)
13.45-14.00 Faith Uwadiae et al (Imperial)
14.00-14.30 Professor Caetano Reis e Sousa (Crick)
14.30-15.00 COFFEE BREAK
 
Session 3: Adaptive immunity: targets for disease Chair: James Harker
15.00-15.30 Professor Claudia Mauri (UCL)
Submitted Abstract
15.30-15.45 Hjh Hanisah Hj Awg Sharif et al (Imperial)
15.45-16.00 Professor Giovanna Lombardi (Kings)
  Break
16.15-17.15 Debate - "What's the better bet for the future of immune therapies, innate or adaptive  All invited speakers (moderator: Suchita Nadkarni)
17.15-19.00 Evening reception with canapés and wine

If you have any queries, please contact BSI London Immunology Group.